Autologous hematopoietic stem cell transplantation for myelodysplastic syndromes: which cell source is preferable?
Lübbert
Michael
M
Department of Hematology/Oncology, Albert-Ludwigs-University, Freiburg, Germany. luebbert@mm11.ukl.uni-freiburg.de
D018380:Hematopoietic Stem Cell Transplantation / Q000401:mortality; D006801:Humans; D015999:Multivariate Analysis; D009190:Myelodysplastic Syndromes / Q000401:mortality / Q000628:therapy*; D014182:Transplantation, Autologous